Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "bupropion"


7 mentions found


Weight gain is also a reason why some stop their medications despite feeling less depressed or anxious while using them. Now, a new study sheds light on just how much weight gain might occur — on average — while taking eight of the most commonly prescribed antidepressants. Weight gain by poundsThe study, published Monday in the journal Annals of Internal Medicine, used electronic health record prescription and body mass to compare weight gain among more than 183,000 people. Not all patients perceive weight gain negatively, although it is more common for patients to want to avoid weight gain than to seek it when taking an antidepressant, Petimar said. “Our study didn’t explore reasons why bupropion was associated with less weight gain than other antidepressants, but other studies have similarly concluded that it is associated with less weight gain than other common antidepressants,” he added.
Persons: Joshua Petimar, paroxetine, Duloxetine, ” Petimar, , Roy Perlis, that's, Joe Raedle, , Petimar, it’s, , bupropion, they’d Organizations: CNN, paroxetine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Internal, escitalopram, , Massachusetts General Hospital Locations: Boston, Massachusetts, ” Perlis, Perlis
The lack of sunlight from shorter winter days can bring on depressive symptoms, and social isolation is common among people with seasonal affective disorder. BenAkiba/E+/Getty ImagesTaking care of your health is key to dealing with seasonal affective disorder. Here’s what experts say you can do to manage seasonal affective disorder. Social isolation is common among people with seasonal affective disorder, and isolating may contribute to depressive symptoms. Antidepressants are another option that Manu recommended for people with severe seasonal affective disorder.
Persons: Joseph Takahashi, , Jason Tucciarone, ” Tucciarone, Tucciarone, Thomas Kilkenny, Kilkenny, Lucian Manu, Manu, Jocelyn Solis, Moreira Organizations: CNN, University of Texas Southwestern Medical Center, Stanford University School of Medicine, Northwell Health, Kilkenny, , Stony Brook Medicine Locations: New York, Tucciarone, Stony
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Blockbuster weight loss and diabetes drugs like Wegovy and Ozempic may be associated with an increased risk of three rare, but severe, stomach conditions in non-diabetic patients, according to a new epidemiological study released Thursday. Their research is the first large, population-level study to examine the risk of serious stomach conditions in non-diabetic patients specifically using GLP-1s for weight loss. People with diabetes are also at increased risk of experiencing stomach paralysis and pancreatitis overall, even without the treatments.
Persons: semaglutide, , Mohit Sodhi Organizations: Blockbuster, JAMA, Novo Nordisk, University of British Columbia, Nordisk Locations: U.S
They can help people with diabetes control their blood sugar and lead to substantial weight loss for people with or without diabetes. Liraglutide was FDA approved as a weight loss medicine since 2014. What’s been less clear is whether patients taking these drugs for weight loss may have the same serious side effects. CNN reached out to Novo Nordisk, the manufacturer of both injectable weight loss drugs examined in this study, for comment. Sodhi said they started the man on a medication that treats stomach paralysis, “and he got a lot better,” Sodhi said.
Persons: Ozempic, , Mahyar, , It’s, Liraglutide, it’s, Mohit Sodhi, Sodhi, Ian Musgrave, Musgrave, What’s, , ” Sodhi, Dr, Sanjay Gupta Organizations: CNN, University of British, US Food and Drug Administration, FDA, , University of Adelaide, Science Media Centre, BMI, Novo Nordisk, CNN Health Locations: University of British Columbia, Australia, Novo
'As startups dive into prescribing hot new weight loss drugs, Hims & Hers is taking a backseat. Its CEO said Hims wants to offer GLP-1s for weight loss, but thinks it's too early. He cited challenges in the young market like insurers refusing to cover GLP-1s and drug shortages. After Hims & Hers' first profitable quarter ever, the startup is thinking about getting in on telehealth's weight-loss craze. An 'inconsistent' supply chainExploding demand for the new weight-loss drugs has also resulted in shortages, which affect all patients prescribed GLP-1s, not just those using the drugs for weight loss.
New York CNN —Amazon is expanding its push into healthcare with a $5 monthly unlimited delivery pass on 60 common generic prescription drugs treating allergies, inflammation, high blood pressure and other conditions. Amazon announced the new delivery service, RXPass, on Tuesday and it will launch immediately in most states except California, Texas, Minnesota and others with specific prescription delivery requirements. The $5-a-month delivery pass is an add-on to Amazon Prime, Amazon’s $139 annual program, and is available exclusively to Prime subscribers regardless of their insurance status. Amazon has long offered a Prime prescription savings benefit to get discounts on generic and brand-name medications. Amazon’s new plan will mean consumers may see lower costs for some generic drugs, Nicholson said.
The Princeton University student who went missing on campus and was found dead in October died by suicide, local prosecutors announced Wednesday. The cause of death of Misrach Ewunetie, 20, was “bupropion, escitalopram and hydroxyzine toxicity,” the Mercer County Prosecutor’s Office said Wednesday, unveiling the autopsy results. Princeton University said in a statement Wednesday: "Our hearts go to Misrach’s family and friends, and to the wider campus community that has been shaken by this tragedy." Her brother, Universe Ewunetie, previously told NBC News their family is originally from Ethiopia and his sister grew up in Euclid, Ohio. You can also call the National Suicide Prevention Lifeline at 800-273-8255, text HOME to 741741 or visit SpeakingOfSuicide.com/resources for additional resources.
Total: 7